How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Close this folder9 REVIEW AND UPDATE
View the documentPlanning for review
View the documentHow frequently does the national formulary need to be reviewed?
Open this folder and view contentsReview process
View the documentREFERENCES
 

Planning for review

The NF will need reviewing and updating in the future due to:

- changes in the list of medicines to be included;
- newly published evidence and changes to treatment guidelines;
- more information becoming known about medicines e.g. side-effects;
- mistakes made in the previous edition of the formulary; and
- changes in government health policy affecting local information.


Some of these changes may be obvious, for example release of a new national EML list. Others are more subtle and may not be immediately obvious, for example, adjustments in prescribing policies leading to changes in the availability of medicines in different types of health facilities.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014